T Cell Receptor-mediated Activation of p38α by Mono-phosphorylation of the Activation Loop Results in Altered Substrate Specificity

被引:45
|
作者
Mittelstadt, Paul R. [1 ]
Yamaguchi, Hiroshi [2 ]
Appella, Ettore [2 ]
Ashwell, Jonathan D. [1 ]
机构
[1] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA
[2] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
STAT4 SERINE PHOSPHORYLATION; ATF2 TRANSCRIPTION FACTOR; P38 MAP KINASE; PROTEIN-KINASE; DUAL PHOSPHORYLATION; ACTIVE MUTANTS; IN-VIVO; GAMMA; EXPRESSION; MECHANISM;
D O I
10.1074/jbc.M901004200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p38 MAPKs are typically activated by upstream MAPK kinases that phosphorylate a Thr-X-Tyr motif in the activation loop. An exception is the T cell antigen receptor signaling pathway, which bypasses the MAPK cascade and activates p38 alpha and p38 beta by phosphorylation of Tyr-323 and subsequent autophosphorylation of the activation loop. Here we show that, unlike the classic MAPK cascade, the alternative pathway results primarily in mono-phosphorylation of the activation loop residue Thr180. Recombinant mono-phosphorylated and dual phosphorylated p38 alpha differed widely with regard to activity and substrate preference. Altered substrate specificity was reproduced in T cells in which p38 was activated by the alternative or classical MAPK pathways. These findings suggest that T cells have evolved a mechanism to utilize p38 in a specialized manner independent of and distinct from the classical p38 MAPK signaling cascade.
引用
收藏
页码:15469 / 15474
页数:6
相关论文
共 50 条
  • [31] Requirement for p56(lck) tyrosine kinase activation in T cell receptor-mediated thymic selection
    Hashimoto, K
    Sohn, SJ
    Levin, SD
    Tada, T
    Perlmutter, RM
    Nakayama, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 931 - 943
  • [32] Activation of RasGRP3 by phosphorylation of Thr-133 is required ifor B cell receptor-mediated Ras activation
    Aiba, Y
    Oh-hora, M
    Kiyonaka, S
    Kimura, Y
    Hijikata, A
    Mori, Y
    Kurosaki, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (47) : 16612 - 16617
  • [33] Receptor-Mediated Vascular Smooth Muscle Migration Induced by LPA Involves p38 Mitogen-Activated Protein Kinase Pathway Activation
    Zhou, Zhi-Bin
    Niu, Jian-Ping
    Zhang, Zhi-Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2009, 10 (07): : 3194 - 3208
  • [34] POLKADOTS are signaling foci in the T cell receptor-mediated activation of NF-κB
    Rossman, Jeremy S.
    Stoicheva, Natalia G.
    Langel, Felicia D.
    Patterson, George H.
    Lippincott-Schwartz, Jennifer
    Schaefer, Brian C.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S199 - S199
  • [35] Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
    Gustafsson, Kristin
    Christensson, Birger
    Sander, Birgitta
    Flygare, Jenny
    MOLECULAR PHARMACOLOGY, 2006, 70 (05) : 1612 - 1620
  • [36] Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-mediated Activation of NFAT
    Shukla, Upasana
    Hatani, Tomoko
    Nakashima, Kenji
    Ogi, Kazuhiro
    Sada, Kiyonao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (49) : 33719 - 33728
  • [37] Rap1-GTP Augments Activation of Smad and p38 Mediated Signaling Downstream of TGF-β Receptor In T Lymphocytes
    Patsoukis, Nikolaos
    Li, Lequn
    Boussiotis, Vassiliki A.
    BLOOD, 2010, 116 (21) : 421 - 421
  • [38] IL10 Inhibits Toll-like Receptor-9-induced T Cell Receptor-mediated T Cell Activation in Macrophage Activation Syndrome
    Eremita, Matthew
    Geier, Omar
    Hui-Yuen, Joyce
    Taylor, Matthew
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1607 - 1609
  • [39] The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses
    Freywald, A
    Sharfe, N
    Rashotte, C
    Grunberger, T
    Roifman, CM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10150 - 10156
  • [40] LKB1 reduces ROS-mediated cell damage via activation of p38
    Xu, H-G
    Zhai, Y-X
    Chen, J.
    Lu, Y.
    Wang, J-W
    Quan, C-S
    Zhao, R-X
    Xiao, X.
    He, Q.
    Werle, K. D.
    Kim, H-G
    Lopez, R.
    Cui, R.
    Liang, J.
    Li, Y-L
    Xu, Z-X
    ONCOGENE, 2015, 34 (29) : 3848 - 3859